Product Name: Erlotinib 150mg Tablet Brand Name: Erlotinib Composition: Erlotinib (150 mg) Form: Tablet Dosage Form: Oral Dose/Strength: 150 mg Packaging Size: 30 Tablets per Strip Packaging Type: Strip Manufacturer: Cipla Prescription Status: Prescription Only Form of Medicine: Allopathic Usage/Application: As directed by a physicianDescription: Erlotinib 150mg Tablet is an oral cancer medication used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) and works by blocking the activity of a specific protein (epidermal growth factor receptor, EGFR) that promotes cancer cell growth.Erlotinib is most effective in patients with EGFR mutation-positive tumors and is often prescribed as a first-line or maintenance therapy in advanced stages of cancer.Indications: Non-small cell lung cancer (NSCLC) Locally advanced or metastatic pancreatic cancer (in combination with gemcitabine) Key Features: Each tablet contains 150 mg of Erlotinib Manufactured by Cipla, a leading global pharmaceutical company Convenient 30-tablet strip packaging Used as part of targeted cancer therapy, offering specificity in treatment
